glp-1 receptor agonists in idiopathic intracranial hypertension medications and pseudotumor cerebri / #pseudotumorcerebri #iih Effect of glucagon like peptide-1
Description
Acute effects of glucagon-like peptide-1, GLP-1(9-36 amide), and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers

and 1.5 and 98.5 centiles) for propensity score weights instead of truncation at 1 and 99 centiles in the primary analyses

LIRA did not significantly alter soluble guanylyl cyclase or endothelial nitric oxide synthase (eNOS) mRNA levels, nor total myocardial eNOS protein expression
Patients who arrive at a new dose already well-hydrated and fiber-sufficient handle the transition significantly better than those who try to adjust after constipation has set in

BW: body weight

AI algorithms can be applied for accelerating drug discovery and development processes like optimizing formulations and dosing strategies for existing drugs as well as for identifying novel compounds which includes plant-derived compounds
